Outset Medical (OM) Net Cash Flow Growth (3y) (2022 - 2026)
Outset Medical (OM) Net Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn | -48.90% |
| 10 | Outset Medical | 79,738.82 | -286.56 Mn | 12.10 Mn | 50.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.59% |
| Dec 31, 2025 | 64.41% |
| Sep 30, 2025 | 35.47% |
| Jun 30, 2025 | 2.17% |
| Mar 31, 2025 | 10.91% |
| Dec 31, 2024 | 57.19% |
| Sep 30, 2024 | 52.90% |
| Jun 30, 2024 | -36.79% |
| Mar 31, 2024 | 5.61% |
| Dec 31, 2023 | 58.34% |
| Sep 30, 2023 | -26.00% |
| Jun 30, 2023 | 26.02% |
| Mar 31, 2023 | -32.08% |
| Dec 31, 2022 | -108.16% |